Transcriptome Analysis of lncRNAs in Pheochromocytomas and Paragangliomas
- 2 November 2019
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (3) , 898-907
Abstract
Context Pheochromocytomas and paragangliomas (PPGL) are neuroendocrine tumors explained by germline or somatic mutations in about 70% of cases. Patients with SDHB mutations are at high risk of developing metastatic disease, yet no reliable tumor biomarkers are available to predict tumor aggressiveness. Objective We aimed at identifying long non-coding RNAs (lncRNAs) specific for PPGL molecular groups and metastatic progression. Design and Methods To analyse the expression of lncRNAs, we used a mining approach of transcriptome data from a well-characterized series of 187 tumor tissues. Clustering consensus analysis was performed to determine a lncRNA-based classification, and informative transcripts were validated in an independent series of 51 PPGL. The expression of metastasis-related lncRNAs was confirmed by RT-qPCR. Receiver operating characteristic (ROC) curve analysis was used to estimate the predictive accuracy of potential markers. Main Outcome Measure Univariate/multivariate and metastasis-free survival (MFS) analyses were carried out for the assessment of risk factors and clinical outcomes. Results Four lncRNA-based subtypes strongly correlated with mRNA expression clusters (chi² p-values from 1.38×10-32 to 1.07×10-67). We identified one putative lncRNA (GenBank: BC063866) that accurately discriminates metastatic from benign tumors in patients with SDHx mutations (AUC 0.95; P = 4.59×10-05). Moreover, this transcript appeared as an independent risk factor associated with poor clinical outcome of SDHx carriers (log-rank test P = 2.29×10-05). Conclusion Our findings extend the spectrum of transcriptional dysregulations in PPGL to lncRNAs and provide a novel biomarker that could be useful to identify potentially metastatic tumors in patients carrying SDHx mutations.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-2011-JCJC-00701)
- Epigénétique et Cancer (EPIG201303)
- Direction Générale de l’offre de Soins (PRT-K 2014, INCa_DGOS_8663)
- Ligue Nationale Contre le Cancer
- European Union Seventh Framework Program (FP7/2007–2013, 259735, 633983)
- Institut National du Cancer and Direction Générale de l’Offre de Soins
This publication has 57 references indexed in Scilit:
- The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expressionGenome Research, 2012
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Landscape of transcription in human cellsNature, 2012
- The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytomaEndocrine-Related Cancer, 2012
- Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclassesGenes & Development, 2011
- Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paragangliomaHuman Molecular Genetics, 2011
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 ResponseCell, 2010
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Genevestigator V3: A Reference Expression Database for the Meta‐Analysis of TranscriptomesAdvances in Bioinformatics, 2008
- A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in PheochromocytomasPLOS Genetics, 2005